{"id":"https://openalex.org/W3209601764","doi":"https://doi.org/10.1016/j.omtn.2021.10.008","title":"Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides","display_name":"Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides","publication_year":2021,"publication_date":"2021-10-20","ids":{"openalex":"https://openalex.org/W3209601764","doi":"https://doi.org/10.1016/j.omtn.2021.10.008","mag":"3209601764","pmid":"https://pubmed.ncbi.nlm.nih.gov/34760338","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8560717"},"language":"en","primary_location":{"id":"doi:10.1016/j.omtn.2021.10.008","doi":"https://doi.org/10.1016/j.omtn.2021.10.008","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.omtn.2021.10.008","pdf_url":"http://www.cell.com/article/S2162253121002511/pdf","source":{"id":"https://openalex.org/S2764969478","display_name":"Molecular Therapy \u2014 Nucleic Acids","issn_l":"2162-2531","issn":["2162-2531"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy - Nucleic Acids","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://www.cell.com/article/S2162253121002511/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060073885","display_name":"Fumito Wada","orcid":"https://orcid.org/0000-0001-6978-1894","observed_orcids":["https://orcid.org/0000-0001-6978-1894"]},"institutions":[{"id":"https://openalex.org/I4405286384","display_name":"National Cerebral and Cardiovascular Center Research Institute","ror":"https://ror.org/01zywn143","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210111404","https://openalex.org/I4405286384"]},{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Fumito Wada","raw_affiliation_strings":["Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan","Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan","Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan"],"raw_orcid":"https://orcid.org/0000-0001-6978-1894","affiliations":[{"raw_affiliation_string":"Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan","institution_ids":["https://openalex.org/I4405286384"]},{"raw_affiliation_string":"Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan","institution_ids":["https://openalex.org/I4405286384"]},{"raw_affiliation_string":"Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019913014","display_name":"Tsuyoshi Yamamoto","orcid":"https://orcid.org/0000-0002-3206-2455","observed_orcids":["https://orcid.org/0000-0002-3206-2455"]},"institutions":[{"id":"https://openalex.org/I43777268","display_name":"Nagasaki University","ror":"https://ror.org/058h74p94","country_code":"JP","type":"education","lineage":["https://openalex.org/I43777268"]},{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tsuyoshi Yamamoto","raw_affiliation_strings":["Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8131, Japan","Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan"],"raw_orcid":"https://orcid.org/0000-0002-3206-2455","affiliations":[{"raw_affiliation_string":"Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8131, Japan","institution_ids":["https://openalex.org/I43777268"]},{"raw_affiliation_string":"Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000509868","display_name":"Tadayuki Kobayashi","orcid":"https://orcid.org/0000-0001-7898-0916","observed_orcids":["https://orcid.org/0000-0001-7898-0916"]},"institutions":[{"id":"https://openalex.org/I4405286384","display_name":"National Cerebral and Cardiovascular Center Research Institute","ror":"https://ror.org/01zywn143","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210111404","https://openalex.org/I4405286384"]},{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tadayuki Kobayashi","raw_affiliation_strings":["Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan","Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan","Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan"],"raw_orcid":"https://orcid.org/0000-0001-7898-0916","affiliations":[{"raw_affiliation_string":"Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan","institution_ids":["https://openalex.org/I4405286384"]},{"raw_affiliation_string":"Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan","institution_ids":["https://openalex.org/I4405286384"]},{"raw_affiliation_string":"Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086288542","display_name":"Keisuke Tachibana","orcid":"https://orcid.org/0000-0003-0044-8772","observed_orcids":["https://orcid.org/0000-0003-0044-8772"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Keisuke Tachibana","raw_affiliation_strings":["Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan"],"raw_orcid":"https://orcid.org/0000-0003-0044-8772","affiliations":[{"raw_affiliation_string":"Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078169098","display_name":"Kosuke Ramon Ito","orcid":"https://orcid.org/0000-0001-5161-1301","observed_orcids":["https://orcid.org/0000-0001-5161-1301"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kosuke Ramon Ito","raw_affiliation_strings":["Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mayumi Hamasaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405286384","display_name":"National Cerebral and Cardiovascular Center Research Institute","ror":"https://ror.org/01zywn143","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210111404","https://openalex.org/I4405286384"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mayumi Hamasaki","raw_affiliation_strings":["Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan","institution_ids":["https://openalex.org/I4405286384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079858647","display_name":"Yukina Kayaba","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I43777268","display_name":"Nagasaki University","ror":"https://ror.org/058h74p94","country_code":"JP","type":"education","lineage":["https://openalex.org/I43777268"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yukina Kayaba","raw_affiliation_strings":["Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8131, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8131, Japan","institution_ids":["https://openalex.org/I43777268"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064121019","display_name":"Chisato Terada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I43777268","display_name":"Nagasaki University","ror":"https://ror.org/058h74p94","country_code":"JP","type":"education","lineage":["https://openalex.org/I43777268"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Chisato Terada","raw_affiliation_strings":["Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8131, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8131, Japan","institution_ids":["https://openalex.org/I43777268"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072796250","display_name":"Asako Yamayoshi","orcid":"https://orcid.org/0000-0002-7527-4255","observed_orcids":["https://orcid.org/0000-0002-7527-4255"]},"institutions":[{"id":"https://openalex.org/I43777268","display_name":"Nagasaki University","ror":"https://ror.org/058h74p94","country_code":"JP","type":"education","lineage":["https://openalex.org/I43777268"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Asako Yamayoshi","raw_affiliation_strings":["Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8131, Japan"],"raw_orcid":"https://orcid.org/0000-0002-7527-4255","affiliations":[{"raw_affiliation_string":"Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8131, Japan","institution_ids":["https://openalex.org/I43777268"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083003749","display_name":"Satoshi Obika","orcid":"https://orcid.org/0000-0002-6842-6812","observed_orcids":["https://orcid.org/0000-0002-6842-6812"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoshi Obika","raw_affiliation_strings":["Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028921297","display_name":"Mariko Harada\u2010Shiba","orcid":"https://orcid.org/0000-0002-7600-2059","observed_orcids":["https://orcid.org/0000-0002-7600-2059"]},"institutions":[{"id":"https://openalex.org/I4405286384","display_name":"National Cerebral and Cardiovascular Center Research Institute","ror":"https://ror.org/01zywn143","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210111404","https://openalex.org/I4405286384"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Mariko Harada-Shiba","raw_affiliation_strings":["Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan","Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan"],"raw_orcid":"https://orcid.org/0000-0002-7600-2059","affiliations":[{"raw_affiliation_string":"Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan","institution_ids":["https://openalex.org/I4405286384"]},{"raw_affiliation_string":"Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-shinmachi, Suita, Osaka 564-8565, Japan","institution_ids":["https://openalex.org/I4405286384"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5028921297"],"corresponding_institution_ids":["https://openalex.org/I4405286384"],"apc_list":{"value":3900,"currency":"USD","value_usd":3900},"apc_paid":{"value":3900,"currency":"USD","value_usd":3900},"fwci":0.6307,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.61825293,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"26","issue":null,"first_page":"957","last_page":"969"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.9869999885559082},{"id":"https://openalex.org/keywords/bridged-nucleic-acids","display_name":"bridged nucleic acids","score":0.9779999852180481},{"id":"https://openalex.org/keywords/liver-targeted-drug-delivery","display_name":"liver-targeted drug delivery","score":0.6970000267028809},{"id":"https://openalex.org/keywords/pcsk9","display_name":"PCSK9","score":0.9459999799728394},{"id":"https://openalex.org/keywords/locked-nucleic-acid","display_name":"locked nucleic acid","score":0.9319999814033508},{"id":"https://openalex.org/keywords/galnac-conjugation","display_name":"GalNAc conjugation","score":0.8769999742507935},{"id":"https://openalex.org/keywords/cholesterol-lowering","display_name":"cholesterol lowering","score":0.7269999980926514},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.8730000257492065},{"id":"https://openalex.org/keywords/nonhuman-primates","display_name":"non-human primates","score":0.6420000195503235},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.4390000104904175}],"concepts":[{"id":"https://openalex.org/C24107716","wikidata":"https://www.wikidata.org/wiki/Q123619","display_name":"Nucleic acid","level":2,"score":0.6998341083526611},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.5690401196479797},{"id":"https://openalex.org/C129312508","wikidata":"https://www.wikidata.org/wiki/Q133686","display_name":"Oligonucleotide","level":3,"score":0.5662553310394287},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.5424637794494629},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5116634368896484},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4989466667175293},{"id":"https://openalex.org/C14363569","wikidata":"https://www.wikidata.org/wiki/Q418639","display_name":"Locked nucleic acid","level":4,"score":0.4942612648010254},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4489259123802185},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.43769770860671997},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38593050837516785},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.32458966970443726},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31936347484588623},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1787182092666626}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.1016/j.omtn.2021.10.008","doi":"https://doi.org/10.1016/j.omtn.2021.10.008","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.omtn.2021.10.008","pdf_url":"http://www.cell.com/article/S2162253121002511/pdf","source":{"id":"https://openalex.org/S2764969478","display_name":"Molecular Therapy \u2014 Nucleic Acids","issn_l":"2162-2531","issn":["2162-2531"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy - Nucleic Acids","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:7466694","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC8560717","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:8560717","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8560717","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Ther Nucleic Acids","raw_type":"Text"},{"id":"pmid:34760338","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34760338","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular therapy. Nucleic acids","raw_type":"Journal Article"},{"id":"pmh:oai:irdb.nii.ac.jp:01160:0005961959","doi":null,"is_oa":true,"landing_page_url":"https://nagasaki-u.repo.nii.ac.jp/records/2000393","pdf_url":"https://nagasaki-u.repo.nii.ac.jp/record/2000393/files/MTNA26_957.pdf","source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Therapy - Nucleic Acids","raw_type":"journal article"},{"id":"pmh:oai:doaj.org/article:abb2609f20634171b35b2ad9423c2d7b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/abb2609f20634171b35b2ad9423c2d7b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Therapy: Nucleic Acids, Vol 26, Iss , Pp 957-969 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.omtn.2021.10.008","doi":"https://doi.org/10.1016/j.omtn.2021.10.008","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.omtn.2021.10.008","pdf_url":"http://www.cell.com/article/S2162253121002511/pdf","source":{"id":"https://openalex.org/S2764969478","display_name":"Molecular Therapy \u2014 Nucleic Acids","issn_l":"2162-2531","issn":["2162-2531"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy - Nucleic Acids","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G23045969","display_name":"Establishment of a new platform for nucleic acid oral formulation technology to realize patient-friendly nucleic acid medicines","funder_award_id":"19H03393","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G3915455566","display_name":"PCSK9\u3092\u30bf\u30fc\u30b2\u30c3\u30c8\u3068\u3057\u305f\u6838\u9178\u533b\u85ac\u306e\u85ac\u4e8b\u7533\u8acb\u3092\u76ee\u6307\u3057\u305f\u6cbb\u9a13\u306b\u6a4b\u6e21\u3057\u3059\u308b\u305f\u3081\u306e\u975e\u81e8\u5e8a\u8a66\u9a13","funder_award_id":"16lk0201028h0003","funder_id":"https://openalex.org/F4320311405","funder_display_name":"Japan Agency for Medical Research and Development"}],"funders":[{"id":"https://openalex.org/F4320311405","display_name":"Japan Agency for Medical Research and Development","ror":"https://ror.org/004rtk039"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3209601764.pdf","grobid_xml":"https://content.openalex.org/works/W3209601764.grobid-xml"},"referenced_works_count":43,"referenced_works":["https://openalex.org/W1526905286","https://openalex.org/W1870321215","https://openalex.org/W1964405385","https://openalex.org/W1966942560","https://openalex.org/W1967660067","https://openalex.org/W1995798120","https://openalex.org/W1998515230","https://openalex.org/W2004130102","https://openalex.org/W2018328995","https://openalex.org/W2024102230","https://openalex.org/W2035062161","https://openalex.org/W2054610237","https://openalex.org/W2065603844","https://openalex.org/W2067539811","https://openalex.org/W2076431356","https://openalex.org/W2078890343","https://openalex.org/W2088358411","https://openalex.org/W2097465728","https://openalex.org/W2114775015","https://openalex.org/W2133380348","https://openalex.org/W2156955518","https://openalex.org/W2173448689","https://openalex.org/W2239874339","https://openalex.org/W2272802497","https://openalex.org/W2304098217","https://openalex.org/W2482598541","https://openalex.org/W2563642244","https://openalex.org/W2607730617","https://openalex.org/W2770396564","https://openalex.org/W2786204496","https://openalex.org/W2900955439","https://openalex.org/W2901670341","https://openalex.org/W2914450987","https://openalex.org/W2942765605","https://openalex.org/W2943158117","https://openalex.org/W2946411003","https://openalex.org/W2964754110","https://openalex.org/W2972949330","https://openalex.org/W2979791917","https://openalex.org/W2980622617","https://openalex.org/W2996200224","https://openalex.org/W3145257564","https://openalex.org/W3160600532"],"related_works":["https://openalex.org/W3002543944","https://openalex.org/W2024479740","https://openalex.org/W2313902532","https://openalex.org/W2004130102","https://openalex.org/W2304715546","https://openalex.org/W2980622617","https://openalex.org/W4253861778","https://openalex.org/W7154631233","https://openalex.org/W2786204496","https://openalex.org/W2173448689"],"abstract_inverted_index":{"Antisense":[0],"oligonucleotides":[1],"(ASOs)":[2],"containing":[3],"bridged":[4],"nucleic":[5,59,64],"acids":[6],"(BNAs)":[7],"have":[8],"been":[9],"proven":[10],"to":[11,106,139,143,160],"be":[12,161],"very":[13],"powerful.":[14],"However,":[15],"ensuring":[16],"a":[17,34,78,83,101,121],"reliable":[18],"discovery":[19],"and":[20,62,85,99],"translational":[21],"development":[22,188],"scheme":[23,44,76,189],"for":[24,193,200],"this":[25],"class":[26],"of":[27,42,48,51,95,114,203],"ASOs":[28,52],"with":[29,172,176],"wider":[30],"therapeutic":[31,147],"windows":[32],"remains":[33],"fundamental":[35],"challenge.":[36],"We":[37],"here":[38],"demonstrate":[39],"the":[40,46,49,140,146,151,173,201],"robustness":[41],"our":[43,186],"in":[45,87,129,168,179],"context":[47],"selection":[50],"having":[53],"two":[54],"different":[55],"BNA":[56],"chemistries":[57],"(2,\u20324\u2032-BNA/locked":[58],"acid":[60,65],"[LNA]":[61],"amido-bridged":[63],"[AmNA])":[66],"targeting":[67],"human":[68],"proprotein":[69],"convertase":[70],"subtilisin/kexin":[71],"type":[72],"9":[73],"(PCSK9).":[74],"The":[75,154],"features":[77],"two-step":[79],"process,":[80],"including":[81],"(1)":[82],"unique":[84],"sensitive":[86],"vitro":[88],"screening":[89],"approach,":[90],"called":[91],"Ca":[92],"2+":[93],"enrichment":[94],"medium":[96],"(CEM)":[97],"transfection,":[98],"(2)":[100],"ligand-targeted":[102],"drug":[103,187],"delivery":[104],"approach":[105],"better":[107,191],"reach":[108],"target":[109],"tissues,":[110],"averting":[111],"unintended":[112],"accumulation":[113],"ASOs.":[115],"Using":[116],"CEM":[117],"screening,":[118],"we":[119,182],"identified":[120],"candidate":[122,141],"ASO":[123,142],"that":[124,185],"shows":[125],">70%":[126],"cholesterol-lowering":[127],"action":[128],"monkeys.":[130],"An":[131],"N":[132],"-acetylgalactosamine":[133],"(GalNAc)":[134],"ligand":[135],"then":[136],"was":[137,158],"appended":[138],"further":[144],"broaden":[145],"margin":[148],"by":[149],"altering":[150],"molecule's":[152],"pharmacokinetics.":[153],"GalNAc":[155],"conjugate,":[156],"HsPCSK9-1811-LNA,":[157],"found":[159],"at":[162],"least":[163],"ten":[164],"times":[165],"more":[166],"potent":[167],"non-human":[169],"primates":[170],"(compared":[171],"unconjugated":[174],"counterpart),":[175],"reduced":[177],"nephrotoxicity":[178],"rats.":[180],"Overall,":[181],"successfully":[183],"showed":[184],"is":[190],"suited":[192],"selecting":[194],"clinically":[195],"relevant":[196],"BNA-based":[197],"ASOs,":[198],"especially":[199],"treatment":[202],"liver-associated":[204],"diseases.":[205]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-11-08T00:00:00"}